The Effect of Oral Powder Enriched with Curcumin and Probiotics on Patients with Metabolic Syndrome

Phase 3

• Conditions: Metabolic syndrome.; Metabolic syndrome; E88.81

• Registration Number: IRCT20220315054290N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 124

Inclusion Criteria

Age: 30-60 years old
Metabolic syndrome patients are diagnosed based on the Adult Treatment Panel III (ATP III) criterion
Consent to participate in the study

Exclusion Criteria

Pregnancy
Lactation
Suffering from kidney, liver, and systemic diseases at the beginning of the study
Metabolic, endocrine, and cardiovascular diseases except diabetes, dyslipidemia, and hypertension
Take any supplements or antibiotics during the previous 3 months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eptin hormone. Timepoint: Before the study and 8 weeks after the start of the study. Method of measurement: Leptin kit (ELISA).;Ghrelin hormone. Timepoint: Before the study and 8 weeks after the start of the study. Method of measurement: Ghrelin kit (ELISA).;Appetite. Timepoint: Before the study and 8 weeks after the start of the study. Method of measurement: Visual Analog Scale (VAS) questionnaire.

Secondary Outcome Measures

Name	Time	Method
Weight. Timepoint: Before the intervention and 8 weeks after the start of the intervention. Method of measurement: Scale.;Waist circumference. Timepoint: Before the intervention and 8 weeks after the start of the intervention. Method of measurement: Inelastic tape.;Body fat percentage. Timepoint: Before the intervention and 8 weeks after the start of the intervention. Method of measurement: Body analyzer device.